Gene: GABPB2
Official Full Name: GA binding protein transcription factor subunit beta 2provided by HGNC
Gene Summary: Enables transcription cis-regulatory region binding activity. Acts upstream of or within positive regulation of transcription by RNA polymerase II. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00434 | GABPB2 knockout cell line (A549) | Human | GABPB2 | 1:3~1:4 | Negative | Online Inquiry |
KO27318 | GABPB2 Knockout cell line (HeLa) | Human | GABPB2 | 1:3~1:6 | Negative | Online Inquiry |
KO27319 | GABPB2 Knockout cell line (HCT 116) | Human | GABPB2 | 1:2~1:4 | Negative | Online Inquiry |
KO27320 | GABPB2 Knockout cell line (HEK293) | Human | GABPB2 | 1:3~1:6 | Negative | Online Inquiry |
GABPB2 Gene Knockout Cell Lines are specifically engineered cell lines where the GABPB2 gene, a crucial transcription factor involved in the regulation of cellular growth, differentiation, and apoptosis, has been deliberately disrupted or "knocked out." This innovative tool enables researchers to study the functional role of GABPB2 in various biological processes and pathophysiological conditions, providing insights into disease mechanisms and therapeutic targets.
The key functions of GABPB2 involve its interaction with DNA to regulate gene expression, particularly in response to various signaling pathways. By employing these knockout cell lines, scientists can elucidate the gene’s contributions to cellular pathways, offering a clearer understanding of its role in conditions such as cancer, metabolic disorders, and neurodegenerative diseases. The mechanism of action is grounded in the loss of functional GABPB2 protein, which allows for comparative studies between wild-type and GABPB2-deficient cells, revealing how the absence of this transcription factor affects cellular behavior and gene expression profiles.
The scientific importance of GABPB2 Gene Knockout Cell Lines is substantial, as they serve as invaluable models for dissecting the underlying biology of diseases associated with GABPB2 dysregulation. In clinical research, these cell lines can be harnessed for drug screening, biomarker identification, and understanding resistance mechanisms to existing therapies.
Compared to alternative models, such as RNA interference or CRISPR-induced modifications that might not fully eliminate gene function, our GABPB2 Gene Knockout Cell Lines offer a robust platform for comprehensive research. This complete knockout reduces potential off-target effects, providing more reliable data for downstream applications.
For researchers and clinicians focused on genetic regulation and disease pathways, GABPB2 Gene Knockout Cell Lines represent a significant advance, enabling clearer insights and facilitating the development of targeted interventions. Our commitment to providing high-quality biological products, coupled with our expertise in genetic engineering and cell line development, ensures that you receive the most reliable and scientifically vetted resources necessary for your cutting-edge research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.